Second U.S. jury finds Bayer's Roundup caused cancer

Second U.S. jury finds Bayer's Roundup caused cancer

Second U.S. jury finds Bayer's Roundup caused cancer

"We continue to believe firmly that the science confirms that glyphosate-based herbicides do not cause cancer", said an online statement from Bayer.

A California court on Tuesday found that Roundup was a "substantial factor" in Edwin Hardeman, 70, getting non-Hodgkin's lymphoma after spraying the weedkiller on his garden for decades.

Carl Tobias, a law professor at the University of Richmond, said Tuesday's decision showed that the August jury verdict was not an aberration and that the Hardeman case could be an indication of what may happen in future similar cases. In Mr Johnson's case, the jury found Monsanto had "acted with malice or oppression" and awarded him US$289 million in damages.

The plaintiff's attorneys said he developed non-Hodgkin lymphoma after 26 years of regularly using Roundup to tackle weeds and poison oak, according to the Wall Street Journal.

He was awarded $US289 million, but that was later reduced to $US78 million.

In the next phase of the federal trial, Mr Hardeman's lawyers will present evidence, including internal Monsanto documents, that could show the company knew the dangers of Roundup and glyphosate and attempted to cover them up. They predict that paying to resolve more than 11,000 related USA lawsuits, which Bayer inherited with its acquisition of Monsanto Co., could cost as much as US$5 billion.

"Today's verdict reinforces what another jury found past year, and what scientists with the state of California and the World Health Organization have concluded: Glyphosate causes cancer in people", Environmental Working Group president Ken Cook said in a statement, referring to the active ingredient in Roundup.

More news: Will Odell Beckham Jr. get new contract with Browns?

It was reported in April past year that Bayer sold 3.6 per cent stake to Temasek for 3 billion euros at 96.77 euros per share.

The steep falls came after a second U.S. jury ruled that blockbuster pesticide Roundup - made by recently-acquired Monsanto - causes cancer. Together with its existing holding in Bayer, Temasek would then own about 4 percent in Bayer after the transaction. In 2016, Hardeman sued Monsanto, which was acquired bythe German pharmaceutical giant Bayer past year.

The ruling is a blow to Bayer, whose subsidiary Monsanto makes the herbicide. It's set to appear in six more trials in federal and state courts this year. Bayer bought St. Louis-based Monsanto, maker of Roundup, last year.

The trial could pave the way for more cases linking glyphosate in Roundup to the development of cancer.

Brokerage Warburg lowered its recommendation to "Hold" from "Buy", arguing that the with the renewed setback upcoming glyphosate court cases would remain a drag on the share price. In the United States, more than 750 products contain it. Among other things, the second phase of the trial will look at whether Monsanto's strategy unduly sought to influence public opinion via scientific reports.

The U.S. Environmental Protection Agency says glyphosate is safe for people when used in accordance with label directions.

Related news